Immune cell therapy for advanced kidney cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new immune therapy that uses your own cells to fight kidney cancer. It combines two types of immune cells to help your body attack the tumor, which may slow its growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have kidney cancer that has been confirmed by biopsy.
- You are over 18 years old.
- You are generally able to do daily activities (performance status 0 or 1).
- You have at least one tumor that can be measured on a scan.
- You have not had chemotherapy or other immune therapy in the last 4 weeks.
- You are not taking steroids or other drugs that suppress the immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental therapy using special immune cells engineered to target a protein called CD70 on kidney cancer cells. It may help patients whose cancer has returned or spread after previous treatment.
This trial is testing a new type of cell therapy for advanced kidney cancer that has not responded to standard treatments. The therapy takes your own immune cells, modifies them to target a protein called CD70 on the cancer cells, and gives them back to you to help fight the cancer.
This trial tests a new drug (JS004) combined with an existing immunotherapy (toripalimab) for kidney cancer that has progressed after previous immunotherapy. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
This trial tests a combination of targeted radiation therapy with a restart of immunotherapy for people whose kidney cancer has grown after prior immunotherapy. It aims to see if radiation can help the immune system fight the cancer again.
This trial tests whether giving immunotherapy before surgery can help people with advanced kidney cancer. The goal is to see if waiting on surgery and starting with medication that boosts the immune system is safe and effective.
This trial tests a new type of cell therapy (CAR-NK cells) designed to target kidney cancer that has spread or cannot be removed with surgery. The cells are engineered in the lab to recognize and attack cancer cells, and may help patients whose cancer has grown despite previous treatments.
Hear when a new Renal Neoplasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.